{{Rsnum
|rsid=727088
|Gene=CD226
|Chromosome=18
|position=69863203
|Orientation=plus
|GMAF=0.4844
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=CD226
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 24.8 | 50.4 | 24.8
| HCB | 44.4 | 48.1 | 7.4
| JPT | 40.5 | 50.5 | 9.0
| YRI | 3.4 | 47.6 | 49.0
| ASW | 5.5 | 61.8 | 32.7
| CHB | 44.4 | 48.1 | 7.4
| CHD | 57.4 | 37.0 | 5.6
| GIH | 19.8 | 53.5 | 26.7
| LWK | 7.5 | 39.6 | 52.8
| MEX | 29.8 | 42.1 | 28.1
| MKK | 5.9 | 38.8 | 55.3
| TSI | 29.0 | 44.0 | 27.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20669283
|Title=A 3'UTR variant is associated with impaired expression of CD226 in T and NK T cells and susceptibility to systemic lupus erythematosus
}}

{{PMID Auto
|PMID=22531499
|Title=A multicentre study confirms CD226 gene association with Systemic Sclerosis-related pulmonary fibrosis
|OA=1
}}

{{PMID Auto GWAS
  |PMID=23128233
  |Trait=Inflammatory bowel disease
  |Title=Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.
  |RiskAllele=G
  |Pval=5E-9
  |OR=1.08
  |ORtxt=[1.046-1.108]
  |OA=1
}}

{{PMID Auto
|PMID=23999715
|Title=CD226 rs763361 (Gly307Ser) Polymorphism Is Associated with Susceptibility to Rheumatoid Arthritis in Zahedan, Southeast Iran
|OA=1
}}

{{PMID Auto
|PMID=23262348
|Title=Association between two genetic variants of CD226 gene and Cervical Squamous Cell Carcinoma: a case-control study.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}